GGrantIndex
← Leaderboards

Sylvia Fitting

Virginia Commonwealth University

$5,745,457
Attributed
$7,391,638
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY201325
$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,391,638 · 8

By mechanism

R01$5,158,342 · 3
R21$1,268,404 · 3
R00$744,512 · 1
K99$220,380 · 1

Top collaborators

Most similar at Virginia Commonwealth University

Same institution · by research overlap

Others in their field

Top investigators on “In Vivo

Research focus

In VivoMediatingIn VitroBehavioralProteinsSynapsesAntiretroviral TherapyBrainEndocannabinoidsHiv-1ExcitotoxicityCognitive DeficitsNeurocognitive DeficitPathologyHiv-Associated Neurocognitive DisorderTransgenic MicePlayPropertyReceptorInjuryNeuroaidsAlzheimer&AposPreventDensity

Grant awards (23)

Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis users$697,390
R01 · FY2025 · DA · contact PI
Circuitry- and cell-specific exploration of CB1R positive allosteric modulators in neuroHIV$416,351
R01 · FY2025 · DA · contact PI
Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis users$702,625
R01 · FY2024 · DA · contact PI
In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis$194,375
R21 · FY2024 · DA · contact PI
Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis users$715,709
R01 · FY2023 · DA · contact PI
In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis$233,250
R21 · FY2023 · DA · contact PI
Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis users$742,666
R01 · FY2022 · DA · contact PI
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo$362,233
R01 · FY2022 · DA · contact PI
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo$362,440
R01 · FY2021 · DA · contact PI
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo$362,640
R01 · FY2020 · DA · contact PI
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo$5,416
R01 · FY2020 · DA · contact PI
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo$362,834
R01 · FY2019 · DA · contact PI
Mapping HIV-Tat +/- endocannabinoid induced synaptic changes at the macromolecular level via cryo-electron tomography$192,138
R21 · FY2019 · DA · contact PI
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo$65,015
R01 · FY2019 · DA · contact PI
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo$363,023
R01 · FY2018 · DA · contact PI
Mapping HIV-Tat +/- endocannabinoid induced synaptic changes at the macromolecular level via cryo-electron tomography$241,834
R21 · FY2018 · DA · contact PI
Opiate drug abuse & HIV-induced excitotoxicity in striatal neurons$249,000
R00 · FY2017 · DA · contact PI
Investigation of endocannabinoid-mediated neuroprotection in models of neuroAIDS$184,321
R21 · FY2017 · DA · contact PI
Opiate drug abuse & HIV-induced excitotoxicity in striatal neurons$246,512
R00 · FY2016 · DA · contact PI
Investigation of endocannabinoid-mediated neuroprotection in models of neuroAIDS$222,486
R21 · FY2016 · DA · contact PI
Opiate drug abuse & HIV-induced excitotoxicity in striatal neurons$249,000
R00 · FY2015 · DA · contact PI
Opiate drug abuse & HIV-induced excitotoxicity in striatal neurons$110,190
K99 · FY2014 · DA · contact PI
Opiate drug abuse & HIV-induced excitotoxicity in striatal neurons$110,190
K99 · FY2013 · DA · contact PI